Authors: Sherman, DG Bes, A Easton, JD Hacke, W Kaste, M Polmar, SH Zivin, JA Fieschi, C Miller, P Schoenfeld, D Street, J Albers, G Atkinson, R Biller, J Bruno, A Carpenter, D Clark, W DeGraba, T Driscoll, P Ellis, J Greenlee, R Hess, D Horowitz, DR Davenport, J Hsu, C Starkman, S Madden, K Pettigrew, C Rosenbaum, D Schim, J Tietjen, G Mansbach, H Edwards, K Webb, R Crisostomo, E Wilterdink, J Rothrock, J Zweifler, R Dexter, J Horowitz, S Futrell, N Alter, M Schneider, D Ferbert, A Hacke, W Prange, H Wiersbitzky, M Buttner, T Schwartz, A Busse, O Klingelhofer, J Kaste, M Erila, T Sivenius, J Sotaniemi, K Liukkonen, J Hedman, C Muuronen, A Rissanen, A Bes, A Feve, JR Mahagne, MH Rancurel, G Trouillas, P Weber, M Thomassen, L Johnsen, HJ Kjallman, L Petersson, J Ferrari, G Lagi, A Mamoli, A Re, G

Citation: Dg. Sherman et al., Use of anti-ICAM-1 therapy in ischemic stroke - Results of the Enlimomab Acute Stroke Trial, NEUROLOGY, 57(8), 2001, pp. 1428-1434